CD4 and cancer: Indeed, the fate of DC transport-independent VACV in the LN paracortex, its interactions with APCs at this site, and the quality of ensuing CD4+ T cell priming are topics that merit further investigation and are likely to contribute to the development of novel vaccine-based counter-measures against infection and cancer.